Neuroinvasion and anosmia are independent phenomena upon infection with SARS-CoV-2 and its variants
Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1
Divergent adaptive immune responses define two types of long COVID
Reduction of SARS-CoV-2 intra-household child-to-parent transmission associated with ventilation
Estimated protection against COVID-19 based on predicted neutralisation titres from Ab measurements
From contact to symptoms – how long was the clock ticking for Omicron
Who self-tested in France during COVID-19, and who didn’t?
SARS-CoV-2 self-test uptake and factors associated with self-testing during Omicron BA. 1 and BA. 2
Lessons from COVID-19 for rescalable data collection.
Enhanced neutralization escape to therapeutic monoclonal antibodies by SARS-CoV2 omicron sublineages
SARS-CoV-2 IgG seroprevalence surveys in blood donors before the vaccination campaign, France 20-21
SARS-CoV-2 incubation period across variants of concern, individual factors, and circumstances
Tocilizumab-treated convalescent COVID-19 patients retain the cross-neutralization potential
The effect of variation of individual infectiousness on SARS-CoV-2 transmission in households
Resistance of Omicron subvariants BA.2.75.2, BA.4.6, and BQ.1.1 to neutralizing antibodies
Impact and mitigation of sampling bias to determine viral spread: Evaluating discrete phylogeography
Longitudinal analysis of serum neutralization of SARS-CoV-2 Omicron BA.2, BA.4, and BA.5